“Alternative Therapies: Anti-TNF (Infliximab, And Adalimumab) Agents And Radiological Response For Refractory Sarcoidosis”. The Review of Diabetic Studies , Sept. 2025, pp. 768-84, https://doi.org/10.70082/bzt09243.